← Leaderboards
Jorge Santana
University Of Puerto Rico Med Sciences
$10,874,849
Attributed
$10,874,849
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2005–06$2M$1.5M$1M$500K$0
'05
'06
Funding mix
By agency
NIH$10,874,849 · 13
By mechanism
U01$10,664,241 · 1
P20$210,608 · 12
Top collaborators
No co-investigators on record.
Most similar at University Of Puerto Rico Med Sciences
Same institution · by research overlap
- Irma L Febo$11,862,123
- Reynold Eugenio Lopez-Enriquez$3,090,813
Others in their field
Top investigators on “Clinical Trial Phase I”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Lawrence Corey · Fred Hutchinson Cancer Center$674,722,986
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$549,289,302
- Barton F Haynes · Duke University$532,133,792
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$407,280,377
Research focus
Clinical Trial Phase IStatistics /BiometryPneumocystis PneumoniaAids Related Neoplasm /CancerAids /Hiv NeuropathyDrug Adverse EffectPathologic ProcessClinical ResearchCooperative StudyCytomegalovirusDrug InteractionsExperimental DesignsGender DifferenceGlucose MetabolismHepatitis B Virus GroupHepatitis C VirusHistoplasmaHiv InfectionsHuman Immunodeficiency Virus 1Human SubjectHuman Therapy EvaluationHydroxyureaImmunoregulationImmunotherapy
Grant awards (19)
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU$1,451,816
U01 · FY2006 · AI · contact PI
A5178: "PEG-IFN PLUS RBV FOR HCV CO-INFECTION"$20,236
P20 · FY2006 · RR · contact PI
A5157 "PILOT STUDY OF ACETYL-L-CARNITINE IN DSPN"$20,226
P20 · FY2006 · RR · contact PI
TDM ON VIRAL LOAD RESPONSE TO PROTEASE INHIBITOR CONTAINING SALVAGE THERAPY$20,221
P20 · FY2006 · RR · contact PI
A5223-SEX DIFFERENCES IN LOPINAVIR/RITONAVIR PHARMACOKINETICS$20,221
P20 · FY2006 · RR · contact PI
ANTIRETROVIRAL EFFECT OF IMMUNIZATION WITH THE MRK AD5 HIV-1 GAG VACCINE$20,221
P20 · FY2006 · RR · contact PI
PILOT STUDY - A5173$20,221
P20 · FY2006 · RR · contact PI
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU$1,569,766
U01 · FY2005 · AI
ACTG-736$14,877
P20 · FY2005 · RR
A5157 "PILOT STUDY OF ACETYL-L-CARNITINE IN DSPN"$14,877
P20 · FY2005 · RR
ATAZANAVIR/ RITONAVIR MAINTENANCE THERAPY$14,877
P20 · FY2005 · RR
ANTIRETROVIRAL EFFECT OF IMMUNIZATION WITH THE MRK AD5 HIV-1 GAG VACCINE$14,877
P20 · FY2005 · RR
TDM ON VIRAL LOAD RESPONSE TO PROTEASE INHIBITOR CONTAINING SALVAGE THERAPY$14,877
P20 · FY2005 · RR
A5126$14,877
P20 · FY2005 · RR
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU$1,562,076
U01 · FY2004 · AI
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU$1,598,938
U01 · FY2003 · AI
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU$1,485,785
U01 · FY2002 · AI
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU$1,510,774
U01 · FY2001 · AI
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU$1,485,086
U01 · FY2000 · AI